ESC 365 - NT-proBNP and cardiopulmonary exercise testing parameters for risk stratification in ATTR-CM

Delegates Premium Access

NT-proBNP and cardiopulmonary exercise testing parameters for risk stratification in ATTR-CM

Session: Cardiac amyloidosis

Topic: Cardiovascular Risk Assessment

Speaker: Mr B. Gregshammer (Vienna, AT)

Event: ESC Preventive Cardiology 2025

Congress Presentation

Add to my library

About the speaker

Mr Bernhard Gregshammer

Vienna (Austria)

0 follower

4 more presentations in this session

Exercise training and Rehabilitation In Cardiac Amyloidosis (ERICA) study: rationale and design

Speaker: Associate Professor A. Marra (Naples, IT)

Cardiopulmonary exercise testing in cardiac amyloidosis - a systematic review and meta-analysis

Speaker: Doctor R. Willixhofer (Milan, IT)

Exercise oscillatory ventilation (EOV) as a predictor of mortality in patients with amyloid cardiomyopathy

Speaker: Doctor R. Willixhofer (Milan, IT)

Association of body mass index with outcomes in patients with amyloid cardiomyopathy

Speaker: Doctor N. Ermolaev (Vienna, AT)

Access the full session

Cardiac amyloidosis

Speakers: Mr B. Gregshammer, Associate Professor A. Marra, Doctor R. Willixhofer, Doctor R. Willixhofer, Doctor N. Ermolaev

About the event

ESC Preventive Cardiology 2025

3 April - 5 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources